Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2326 AL 2340

Correcting SUVR bias by accounting for radiotracer clearance in tissue: A validation study with [(18)F]FE-PE2I PET in cross-sectional, test-retest and longitudinal cohorts

Oh M, Honhar P, Carson RE, Hillmer AT, Varrone A.

J Cereb Blood Flow Metab. 2025 Jul;45(7):1357-1370. doi: 10.1177/0271678X251322407. Epub 2025 Feb 21.

Broad-Spectrum Therapeutic Potentials of the Multifaceted Triterpene Lupeol and Its Derivatives

Parvez A, Rahman MA, Rahman MM, Shimki AI, Ahmmed S, Supti FA, Hasan MH, Bristi MSA, Ansari SA, Islam MT.

Chem Biodivers. 2025 Jul;22(7):e202402286. doi: 10.1002/cbdv.202402286. Epub 2025 Mar 13.

Boostering diagnosis of frontotemporal lobar degeneration with AI-driven neuroimaging - A systematic review and meta-analysis

Wu Q, Kiakou D, Mueller K, Köhler W, Schroeter ML.

Neuroimage Clin. 2025;45:103757. doi: 10.1016/j.nicl.2025.103757. Epub 2025 Feb 17.

LRRK2, lysosome damage, and Parkinson's disease

Bentley-DeSousa A, Clegg D, Ferguson SM.

Curr Opin Cell Biol. 2025 Apr;93:102482. doi: 10.1016/j.ceb.2025.102482. Epub 2025 Feb 20.

GLP-1 receptor agonists, are we witnessing the emergence of a paradigm shift for neuro-cardio-metabolic disorders?

Arredouani A.

Pharmacol Ther. 2025 May;269:108824. doi: 10.1016/j.pharmthera.2025.108824. Epub 2025 Feb 19.

Striatal dopamine D2/D3 receptor regulation of human reward processing and behaviour

Osugo M, Wall MB, Selvaggi P, Zahid U, Finelli V, Chapman GE, Whitehurst T, Onwordi EC, Statton B, McCutcheon RA, Murray RM, Marques TR, Mehta MA, Howes OD.

Nat Commun. 2025 Feb 21;16(1):1852. doi: 10.1038/s41467-025-56663-7.

Cross-evaluation of wearable data for use in Parkinson's disease research: a free-living observational study on Empatica E4, Fitbit Sense, and Oura

Reithe H, Marty B, Torrado JC, Førsund E, Husebo BS, Erdal A, Kverneng SU, Sheard E, Tzoulis C, Patrascu M.

Biomed Eng Online. 2025 Feb 21;24(1):22. doi: 10.1186/s12938-025-01353-0.

Invasive therapies for Parkinson's disease: an adapted excerpt from the guidelines of the German Society of Neurology

Reese R, Koeglsperger T, Schrader C, Tönges L, Deuschl G, Kühn AA, Krack P, Schnitzler A, Storch A, Trenkwalder C, Höglinger GU; German Parkinson‘s Guideline Group.

J Neurol. 2025 Feb 22;272(3):219. doi: 10.1007/s00415-025-12915-6.

Glucose Metabolic Reprogramming in Microglia: Implications for Neurodegenerative Diseases and Targeted Therapy

Fang M, Zhou Y, He K, Lu Y, Tao F, Huang H.

Mol Neurobiol. 2025 Jul;62(7):8204-8221. doi: 10.1007/s12035-025-04775-y. Epub 2025 Feb 22.

A Comprehensive Review on Utilizing Human Brain Organoids to Study Neuroinflammation in Neurological Disorders

Rubio AD, Hamilton L, Bausch M, Jin M, Papetti A, Jiang P, Yelamanchili SV.

J Neuroimmune Pharmacol. 2025 Feb 22;20(1):23. doi: 10.1007/s11481-025-10181-x.

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Nervous System Disorders: A Systematic Review and Meta-Analysis

Xu B, Yang M, Li S, Kang B, Zhou J.

Ann Pharmacother. 2025 Sep;59(9):809-821. doi: 10.1177/10600280251317495. Epub 2025 Feb 23.

Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet

Khowdiary MM, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Elhenawy AA, Babalghith AO, Shokr MM, Alexiou A, Papadakis M, El-Saber Batiha G.

Eur J Pharmacol. 2025 May 15;995:177419. doi: 10.1016/j.ejphar.2025.177419. Epub 2025 Feb 21.

Synaptic Interactions Between Serotonergic and Dopaminergic Systems in Parkinson's Disease

Marino G, Campanelli F, Natale G, De Carluccio M, Servillo F, Ghiglieri V, Calabresi P.

Curr Neuropharmacol. 2025;23(9):1021-1035. doi: 10.2174/011570159X336597241217062042.

Bibliometric Analysis of Alpha-Synuclein Determination by Biopsy in Peripheral Tissues of Patients With Parkinson's Disease

Utegenova AB, Yermagambetova AP, Kabdrakhmanova GB, Khamidulla AA, Urasheva ZU, Kenzhinа NK, Zhussupova Z, Nurlanova GN.

Int J Telemed Appl. 2025 Feb 14;2025:6469893. doi: 10.1155/ijta/6469893. eCollection 2025.

Gut microbiota: A new window for the prevention and treatment of neuropsychiatric disease

Tang Y, Zhang Y, Chen C, Cao Y, Wang Q, Tang C.

J Cent Nerv Syst Dis. 2025 Feb 21;17:11795735251322450. doi: 10.1177/11795735251322450. eCollection 2025.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias